-
1
-
-
0033963629
-
A review of clinical trials with fluoroquinolones with an emphasis on new agents
-
Blondeau J.M. A review of clinical trials with fluoroquinolones with an emphasis on new agents. Expert Opin. Investig. Drugs. 9:2000;383-413.
-
(2000)
Expert Opin. Investig. Drugs
, vol.9
, pp. 383-413
-
-
Blondeau, J.M.1
-
3
-
-
0034087347
-
In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA
-
McCloskey L., Moore T., Niconovich N., et al. In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA. J. Antimicrob. Chemother. 45:2000;13-21.
-
(2000)
J. Antimicrob. Chemother.
, vol.45
, pp. 13-21
-
-
McCloskey, L.1
Moore, T.2
Niconovich, N.3
-
4
-
-
0034534006
-
In vitro activity of gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers and assessment of disk diffusion test interpretive criteria
-
Fuchs P.C., Barry A.L., Brown S.D. In vitro activity of gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers and assessment of disk diffusion test interpretive criteria. Diag. Microbiol. Infect. Dis. 38:2000;243-253.
-
(2000)
Diag. Microbiol. Infect. Dis.
, vol.38
, pp. 243-253
-
-
Fuchs, P.C.1
Barry, A.L.2
Brown, S.D.3
-
5
-
-
0008328298
-
In vitro susceptibility of 4768 bacterial isolates to gemifloxacin - An advanced fluoroquinolone
-
Toronto, ON, Canada, September 17-20, American Society of Microbiology, Washington, DC. Abstract E2309
-
Blondeau JM, Borsos S. In vitro susceptibility of 4768 bacterial isolates to gemifloxacin - an advanced fluoroquinolone, 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, ON, Canada, September 17-20, 2000. American Society of Microbiology, Washington, DC. Abstract E2309.
-
(2000)
40th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Blondeau, J.M.1
Borsos, S.2
-
6
-
-
0033595136
-
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
-
Chen D.K., McGeer A., De Azavedo J., Low D.E. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341:1999;233-239.
-
(1999)
N. Engl. J. Med.
, vol.341
, pp. 233-239
-
-
Chen, D.K.1
McGeer, A.2
De Azavedo, J.3
Low, D.E.4
-
7
-
-
0036233721
-
Activities of new fluoroquinolones, ketolides and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000
-
Gershon A.S., De Azavedo J., McGeer A., et al. Activities of new fluoroquinolones, ketolides and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000. Antimicrob. Agents Chemother. 46:2002;1553-1556.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 1553-1556
-
-
Gershon, A.S.1
De Azavedo, J.2
McGeer, A.3
-
8
-
-
0036242204
-
Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000
-
Low D.E., De Azavedo J., Weiss K., et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob. Agents Chemother. 46:2002;1295-1301.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 1295-1301
-
-
Low, D.E.1
De Azavedo, J.2
Weiss, K.3
-
9
-
-
0034989717
-
Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents
-
Blondeau J.M., Vaughan D., Laskowski R., Borsos S. Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents. Int. J. Antimicrobial. Agents. 17:2001;457-464.
-
(2001)
Int. J. Antimicrobial. Agents
, vol.17
, pp. 457-464
-
-
Blondeau, J.M.1
Vaughan, D.2
Laskowski, R.3
Borsos, S.4
-
10
-
-
0034053256
-
Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms
-
Blondeau J.M., Laskowski R., Bjarnason J., Stewart C. Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms. Int. J. Antimicrobial. Agents. 14:2000;45-50.
-
(2000)
Int. J. Antimicrobial. Agents
, vol.14
, pp. 45-50
-
-
Blondeau, J.M.1
Laskowski, R.2
Bjarnason, J.3
Stewart, C.4
-
11
-
-
0033751574
-
A comparative in vitro surveillance study of gemifloxacin activities against 2632 recent Streptococcus pneumoniae isolates from across Europe, North America and South America
-
Hoban D.J., Bouchillon S.K., Karlowsky J.A., et al. A comparative in vitro surveillance study of gemifloxacin activities against 2632 recent Streptococcus pneumoniae isolates from across Europe, North America and South America. Antimicrob. Agents Chemother. 44:2000;3008-3011.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 3008-3011
-
-
Hoban, D.J.1
Bouchillon, S.K.2
Karlowsky, J.A.3
-
12
-
-
0033734978
-
Activities of clinafloxacin, gatifloxacin, gemifloxacin and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae
-
Jorgensen J.H., Weigel L.M., Swenson J.M., Whitney C.G., Ferraro M.J., Tenover F.C. Activities of clinafloxacin, gatifloxacin, gemifloxacin and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44:2000;2962-2968.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 2962-2968
-
-
Jorgensen, J.H.1
Weigel, L.M.2
Swenson, J.M.3
Whitney, C.G.4
Ferraro, M.J.5
Tenover, F.C.6
-
13
-
-
0035873488
-
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999
-
Hoban D.J., Doern G.V., Fluit A.C., Roussel-Delvallez M., Jones R.N. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32:2001;S81-S93.
-
(2001)
Clin. Infect. Dis.
, vol.32
-
-
Hoban, D.J.1
Doern, G.V.2
Fluit, A.C.3
Roussel-Delvallez, M.4
Jones, R.N.5
-
14
-
-
0035139520
-
Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae
-
Blondeau J.M., Zhao X., Hansen G., Drlica K. Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 45:(15):2001;433-438.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, Issue.15
, pp. 433-438
-
-
Blondeau, J.M.1
Zhao, X.2
Hansen, G.3
Drlica, K.4
-
15
-
-
0012633187
-
Comparison of gatifloxacin (GA), gemifloxacin (GM), levofloxacin (L) and moxifloxacin (M) by the mutation prevention concentration (MPC) using 160 clinical isolates of Streptococcus pneumoniae (SP)
-
Chicago, IL, September 20-22, American Society of Microbiology, Washington, DC. Abstract #76
-
Blondeau JM, Hansen G, Zhao X, Drlica K. Comparison of gatifloxacin (GA), gemifloxacin (GM), levofloxacin (L) and moxifloxacin (M) by the mutation prevention concentration (MPC) using 160 clinical isolates of Streptococcus pneumoniae (SP). 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 20-22, 2001. American Society of Microbiology, Washington, DC. Abstract #76.
-
(2001)
40th Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Blondeau, J.M.1
Hansen, G.2
Zhao, X.3
Drlica, K.4
-
16
-
-
0037229075
-
Mutant prevention concentration of gemifloxicin for clinical isolates of Streptococcus pneumoniae
-
Hansen G., Drlica K., Blondeau J.M. Mutant prevention concentration of gemifloxicin for clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 47:(1):2003;440-441.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, Issue.1
, pp. 440-441
-
-
Hansen, G.1
Drlica, K.2
Blondeau, J.M.3
|